Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study | RMD Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Infections

Original research

Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study

Online download statistics by month:

Online download statistics by month: December 2021 to March 2024

	Abstract	Full	Pdf
Dec 2021	357	358	127
Jan 2022	129	140	46
Feb 2022	217	218	34
Mar 2022	114	117	31
Apr 2022	107	107	14
May 2022	64	66	30
Jun 2022	45	44	9
Jul 2022	66	69	18
Aug 2022	52	52	8
Sep 2022	45	50	15
Oct 2022	58	58	13
Nov 2022	29	28	15
Dec 2022	21	21	5
Jan 2023	35	33	15
Feb 2023	56	58	17
Mar 2023	32	26	8
Apr 2023	23	20	10
May 2023	21	21	11
Jun 2023	16	16	7
Jul 2023	23	21	7
Aug 2023	16	15	9
Sep 2023	14	14	2
Oct 2023	14	14	9
Nov 2023	22	21	7
Dec 2023	20	19	5
Jan 2024	17	16	4
Feb 2024	20	18	13
Mar 2024	23	19	41
Total	1656	1659	530